logo

Development of Alendronate conjugated Poly lactic co

If you want to confirm some technical details before you order,
just need to send a message or e-mail: [email protected].
Then our professional sales staff will contact you within 2 hours.

Development of Alendronate-conjugated Poly (lactic-co-glycolic acid)-Dextran Nanoparticles for... - Abstract - Europe P

Abstract: In this study, we developed a novel poly (lactic-co-glycolic acid)-dextran (PLD)-based nanodelivery system to enhance the anticancer potential of...

Development of an Alendronate Controlled Delivery System for Bone Repair Applicatio

Poly lactic-co-glycolic acid (PLGA) is a copolymer approved to be safe in pharmaceutical applications by the FDA due to its biocompatibility and biodegradability. ...

Formulation and In Vitro Evaluation of Alendronate Sodium/PLGA Microspheres for Applications in Bone Related Disorde

Andreea-Gabriela Deca et al. - Formulation and characterization of alendronate sodium/PLGA microspheres Original Paper ... The purpose of the present study was to include sodium alendronate(AL) in poly (lactic-co-glycolic acid) (PLGA) microspheres with a ...

The Effect of Poly(d,l-Lactide-co-Glycolide)-Alendronate Conjugate Nanoparticles on Human Osteoclast Precursors: Journal of Biomaterials Science .

With this aim, we have produced NPs made of poly(d,l-lactide-co-glycolide) (PLGA) conjugated with alendronate (ALE). To show if ALE retained the antiosteoclastic properties after the conjugation with PLGA and the production of NPs, we treated human ...

Publications Authored by Rong-jie Feng | PubFac

Retraction: Development of Alendronate-conjugated Poly (lactic-co-glycolic acid)-Dextran Nanoparticles for Active Targeting of Cisplatin in Osteosarcoma. Authors: ...

Development of Alendronate-conjugated Poly (lactic-co-glycolic acid)-Dextran Nanoparticles for Active Targeting of Cisplatin in Osteosarco

SCIENTIFIC REPORTS 517387 DI 10.1038/srep17387 1 www.nature.com/scientificreports Development of Alendronate-conjugated Poly (lactic-co-glycolic acid)-Dextran Nanoparticles for Active Targeting of Cisplatin in Osteosarcoma Ping Liu1, LiangSun 2, Dong ...

The Effect of Poly(d,l-Lactide-co-Glycolide)-Alendronate Conjugate Nanoparticles on Human Osteoclast Precursors: Journal of Biomaterials Science .

With this aim, we have produced NPs made of poly(d,l-lactide-co-glycolide) (PLGA) conjugated with alendronate (ALE). To show if ALE retained the antiosteoclastic properties after the conjugation with PLGA and the production of NPs, we treated human ...

Development of a Poly (lactic-co-glycolic acid) Particle Vaccine to Protect Against House Dust Mite Induced Aller

Development of a Poly (lactic-co-glycolic acid) Particle Vaccine to Protect Against House Dust Mite Induced Allergy Vijaya B. Joshi,1 Andrea Adamcakova-Dodd,2 Xuefang Jing,2 Amaraporn Wongrakpanich,1 ...

Development of Alendronate-conjugated Poly (lactic-co-glycolic acid)-Dextran Nanoparticles for Active Targeting of Cisplatin in Osteosarcoma .

Development of Alendronate-conjugated Poly (lactic-co-glycolic acid)-Dextran Nanoparticles for Active Targeting of Cisplatin in Osteosarcoma Development of Alendronate-conjugated Poly (lactic-co-glycolic acid)-Dextran Nanoparticles for Active Targeting of ...

Development of a Poly(d,l-lactic-co-glycolic acid) Nanoparticle Formulation of STAT3 Inhibitor JSI-124: Implication for Cancer Immunotherapy .

Development of a Poly(d,l-lactic-co-glycolic acid) Nanoparticle Formulation of STAT3 Inhibitor JSI-124: Implication for Cancer Immunotherapy ADVERTISEMENT Log In Register Cart ACS ACS Publications C&EN CAS ACS Journals C&EN A ACS Applied Energy ...

(PDF) Development of Alendronate-conjugated Poly (lactic-co-glycolic acid)-Dextran Nanoparticles for Active Targeting of Cisplatin in Osteosarco

PDF | In this study, we developed a novel poly (lactic-co-glycolic acid)-dextran (PLD)-based nanodelivery system to enhance the anticancer potential of cisplatin (CDDP) in osteosarcoma cells. A nanosized CDDP-loaded PLGA-DX nanoparticle (PLD/CDDP ...

Development of surface-engineered PLGA nanoparticulate-delivery system | I

Development of surface-engineered PLGA nanoparticulate-delivery system of Tet-1-conjugated nattokinase enzyme for inhibition of ABeta40 plaques in Alzheimer's disease Prakash Chandra Bhatt,1 Amita Verma,2 Fahad A Al-Abbasi,3 Firoz Anwar,3 Vikas Kumar,4 ...

Development of Alendronate-conjugated Poly (lactic-co-glycolic acid)-Dextran Nanoparticles for Active Targeting of Cisplatin in Osteosarcoma .

Drug & Process Development Genomic Solutions Analytical / Chromatography Production Materials Industries Academic Research Agriculture Biotechnology Cell Therapy Manufacturing Chemical Manufacturing R&D Clinical Diagnostics Cosmetics & Personal ...

Retraction: Development of Alendronate-conjugated Poly (lactic-co-glycolic acid)-Dextran Nanoparticles for Active Targeting of Cisplatin in .

Retraction: Development of Alendronate-conjugated Poly (lactic-co-glycolic acid)-Dextran Nanoparticles for Active Targeting of Cisplatin in Osteosarcoma ...

Biocompatibility of poly(d,l-lactide-co-glycolide) nanoparticles conjugated with alendronate — Italian Ministry of Heal

Nanoparticles made of a conjugate of poly(d,l-lactide-co-glycolide) with alendronate (PLGA-ALE NPs), were prepared by emulsion/solvent evaporation technique. The conjugation yield, determined by MALDI TOF analysis, was 30-35%. PLGA-ALE NPs size ...

Development of Alendronate-conjugated Poly (lactic-co-glycolic acid)-Dextran N

Abstract In this study, we developed a novel poly (lactic-co-glycolic acid)-dextran (PLD)-based nanodelivery system to enhance the anticancer potential of cisplatin (CDDP) in osteosarcoma cells. A nanosized CDDP-loaded PLGA-DX nanoparticle (PLD/CDDP ...

Open Repository of National Natural Science Foundation of China: Browsing NSFC-

Biphasic silica/apatite co-mineralized collagen scaffolds stimulate osteogenesis and inhibit RANKL-mediated ... Cutler CW; Pashley DH; Tay FR. 2015 Development of Alendronate-conjugated Poly (lactic-co-glycolicacid)-Dextran Nanoparticles forActive Liu P; ; ...

Development of Alendronate-conjugated Poly (lactic-co-glycolic acid)-Dextran Nanoparticles for Active Targeting of Cisplatin in Osteosarco

How to cite this article: Liu, P. et al. Development of Alendronate-conjugated Poly (lactic-co-glycolic acid)-Dextran Nanoparticles for Active Targeting of Cisplatin ...

Development of surface-engineered PLGA nanoparticulate-delivery system | I

Development of surface-engineered PLGA nanoparticulate-delivery system of Tet-1-conjugated nattokinase enzyme for inhibition of ABeta40 plaques in Alzheimer's disease Prakash Chandra Bhatt,1 Amita Verma,2 Fahad A Al-Abbasi,3 Firoz Anwar,3 Vikas Kumar,4 ...

Development of docetaxel and alendronate-loaded chitosan-conjugated polylactide-co-glycolide nanoparticles: In vitro characterization in .

Development of docetaxel and alendronate-loaded chitosan-conjugated polylactide-co-glycolide nanoparticles: In vitro characterization in osteosarcoma cells Ya-Feng Liu*, Rui Liu, ...

Open Repository of National Natural Science Foundation of China: Development of Alendronate-conjugated Poly (lactic-co-glycolicacid)-Dextran .

Development of Alendronate-conjugated Poly (lactic-co-glycolicacid)-Dextran Nanoparticles forActive Targeting of Cisplatin inOsteosarcoma Development of Alendronate-conjugated Poly (lactic-co-glycolicacid)-Dextran Nanoparticles forActive Targeting of Sun L; ...